Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients - Top-Institutions - MDSpire

Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients

  • By

  • Qamar J. Khan

  • Cory R. Bivona

  • Ben Liu

  • Maggie Nelson

  • Grace A. Martin

  • Muhammad Umair Mushtaq

  • Priyanka Sharma

  • Natalie R. Streeter

  • Marc Hoffmann

  • Gary C. Doolittle

  • Cuncong Zhong

  • Laura Mitchell

  • Kevin H. Li

  • Ziyan Y. Pessetto

  • Arnab Ghosh

  • Harsh B. Pathak

  • Jun Zhang

  • Andrew K. Godwin

  • Joseph P. McGuirk

  • April 6, 2022

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Immunology
    • Infectious Diseases

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology/Oncology
    • Immunotherapy
    • Infectious Diseases

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology/Oncology
    • Transplantation
    • Immunology

  • #4

    University of Washington Medical Center
    University of Washington Medical Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Infectious Diseases
    • Immunology

  • #5

    University of Kansas Medical Center
    University of Kansas Medical Center

    Kansas City, KS

    Key Differentiators

    • Hematology/Oncology
    • Transplantation
    • Infectious Diseases

Original Source(s)

Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients

  • by Qamar J. Khan, Cory R. Bivona, Ben Liu, Maggie Nelson, Grace A. Martin, Muhammad Umair Mushtaq, Priyanka Sharma, Natalie R. Streeter, Marc Hoffmann, Gary C. Doolittle, Cuncong Zhong, Laura Mitchell, Kevin H. Li, Ziyan Y. Pessetto, Arnab Ghosh, Harsh B. Pathak, Jun Zhang, Andrew K. Godwin, Joseph P. McGuirk

  • April 6, 2022

Related Content

Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients

Severe Parvovirus B19–Associated Myocarditis in Children in the Post–COVID-19 Era: A Multicenter Observational Cohort Study

Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season